Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar)
Viroj Wiwanitkit1–31Wiwanitkit House, Bang Khae, Bangkok, Thailand; 2Hainan Medical University, Haikou, Hainan, People's Republic of China; 3Joseph Ayo Babalola University, Ikeji-Arakeji, Osun State, NigeriaAbstract: Leishmaniasis is an important vector-borne disease, and i...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-06-01
|
Series: | Therapeutics and Clinical Risk Management |
Online Access: | http://www.dovepress.com/interest-in-paromomycin-for-the-treatment-of-visceral-leishmaniasis-ka-a10203 |